Daily News and Tips
(HealthDay)—For patients with type 2 diabetes taking metformin monotherapy, the bile acid sequestrant colesevelam reduces fasting and postprandial glucose concentrations without any effects on insulin concentration, secretion, …
Posted in: Medical Research News | Disease/Infection News Tags: Bacteria, Blood, Blood Pressure, DNA, Drugs, Immune System, Laboratory, Low Blood…
How post-meal insulin surge is a normal beneficial physiological response New Research Challenges Notion That Post-Meal Insulin Surge is a…
Man Dies From Nosebleed, Wife Sues Hospital